Skip to content
Home/Companies/Healthcare/HemoDynes
HemoDynes

HemoDynes

Healthcare·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns HemoDynes?

HemoDynes is currently owned by 50 Partners through 50 Partners Capital Health (2022 vintage), since 2021.

Hand-verified · updated 2026-04-21

50 Partners
Investor
50 Partners
50 Partners Capital Health · 2022 · VC

Key facts

HQFrance
SectorHealthcare
Websitehemodynes.com

More from 50 Partners Capital Health

Other portfolio companies in the same fund.

BioHive
Active
HealthcareFrance· 2025
Clear Surgery
Clear Surgery
Active
HealthcareFrance· 2025
En Carta Diagnostics
Active
HealthcareFrance· 2025
Ensweet
Ensweet
Active
HealthTechFrance· 2024
BeLiver
BeLiver
Active
HealthcareFrance· 2023
Oteo
Oteo
Active
HealthcareFrance· 2023

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track HemoDynes

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy HemoDynes?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on HemoDynes.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue